Currently<unk>  does not have any standard treatment and does not have a cure. However, a person suffering from the<unk>  needs proper nutrition, hydration, and maintenance of clear airways. To reduce some symptoms that may occur with<unk> , the patient may take anticonvulsants to manage seizures or medications to treat respiratory infections, and consume a precise diet consisting of puree foods due to difficulties swallowing. Infants with the<unk>  usually die by the age of 3 due to respiratory infections. The patient must be under constant surveillance because they can suffer from aspiration or lack the ability to change from the passageway to their lungs versus their stomach and their spit travels to the lungs causing bronchopneumonia. The patient also lacks the ability to cough and therefore must undergo a treatment to shake up their body to remove the mucus from the lining of their lungs. Medication is also given to patients to lessen their symptoms including seizures. Currently the government is testing several treatments including N-butyl-deoxynojirimycin in mice, as well as stem cell treatment in humans and other medical treatments recruiting test patients. A<unk>  study showing proof of principle for gene therapy in a human model system using CRISPR and virus gene correction gives the chance for clinical trials to cure the<unk> . The ultra-rare occurrence is a main hurdle to overcome for clinical trials.
Sandhoff disease
Tay–Sachs disease
Stratton Parker syndrome
Menkes disease
Gerstmann–Sträussler–Scheinker syndrome
Scheie syndrome
Aceruloplasminemia
Batten disease